Lung Cancer

Lung Cancer Webinars

Bringing experiences together

Welcome to the Siemens Healthineers Lung Cancer Webinar series, designed to provide healthcare professionals, researchers, and patients with the latest information and insights on lung cancer screening, diagnosis and treatment. Our webinars feature leading experts in the field of oncology who share their perspectives on the latest advancements in lung cancer. 

  • PD Dr. med. Isabelle Ayx, Consultant Radiologist, Scientific Head of the Center of Cardiovascular Imaging at the University Medical Centre Mannheim: "Unpacking Lung Cancer Screening - The Why and How".
  • Prof. Nicola Sverzellati, Professor of Radiology at the Department of Medicine and Surgery, University of Parma, Italy: “What to know about your Lung-RADS score?”
  • Prof. Dr. Isabelle Opitz, Director of the Clinic for Thoracic Surgery at the University Hospital Zurich: "New frontiers in thoracic surgery – Implications of lung cancer screening on surgical therapy”
  • Explore the morbidity and mortality of lung cancer worldwide.
  • Understand the benefits, risks, and risk-based inclusion criteria associated with lung cancer screening (LCS).
  • Familiarize yourself with the Lung-RADS 2022 categories, the management of nodules, and the implications of early detection on thoracic surgery.
  • Gain insight into the advantages of AI integration in lung cancer care, benefiting patients, clinicians, and the healthcare system.
  • Evaluate the challenges and requirements associated with implementing AI support for reading and reporting in lung cancer screening programs.
  • Recognize the indispensable role of multidisciplinary teamwork in optimizing lung cancer care pathways and enhancing patient outcomes.
  • Understand the significance of lung cancer screening programs in detecting the disease at earlier stages and their impact on treatment approaches, particularly in thoracic surgery.
  • Explore advanced minimal invasive techniques such as video-assisted thoracoscopic surgery and robotic techniques in thoracic surgery for lung cancer.
  • Recognize the crucial role of multidisciplinary collaboration in interpreting imaging, determining optimal diagnostic and treatment approaches, and advancing new techniques for lung cancer treatment.
  • Understand the added value of Tin Filter in lung cancer screening CT assessment, including its ability to reduce radiation dose while maintaining image quality and characterizing various types of nodules.
  • Evaluate the status of lung cancer screening programs in Italy, including the development of national networks and challenges in implementation and requirements.
  • Recognize the importance of multidisciplinary teamwork in effectively diagnosing and treating lung cancer, and the potential role of industry support in enhancing early diagnosis and therapeutic options through integrated imaging technology and therapeutic advancements.

Join Professor Rozemarijn Vliegenthart, radiologist and professor of cardiothoracic imaging at the Data Science Center in Health, Universitair Medisch Centrum Groningen, The Netherlands, as she explores the expanding role of low-dose chest CT beyond lung cancer screening. Discover how these scans provide insight into degenerative diseases such as coronary artery disease and chronic obstructive pulmonary disease, paving the way for early intervention. Delve into the ongoing debate about the interpretation of early CT signs and the critical role of AI software in this process.

  • Understand the potential of low-dose chest CT to detect degenerative disease beyond lung nodules.
  • Recognize the importance of early detection in improving outcomes for conditions such as coronary artery disease and chronic obstructive pulmonary disease.
  • Explore the evolving landscape of radiology practice, including the use of AI software for imaging biomarkers and management of incidental findings.

Video Archive

Welcome to the Lung Cancer Screening Archive! Our curated collection of expert-led videos and discussions offers timeless insights into advancements in lung cancer screening. Although the content may be from previous years, it remains a valuable and reliable source of information, providing current best practices and knowledge in the field. Delve into topics such as program implementation, the role of AI, and the importance of pulmonologists in driving lung cancer screening efforts.
  • Sebastian Schmidt, Senior Manager for Medical Affairs at Siemens Healthineers Forchheim
    “ Update on lung screening in Europe”
  • Ante Marušić, MD, PhD, LCS Team, Zagreb, Croatia
    “Three years after the first lung screening: experience sharing from Croatia”
  • Rozemarijn Vliegenthart, MD, PhD, Professor of Radiology at the University of Groningen, the Netherlands
    “Lung screening: current challenges and solutions”
  • Felix Herth, MD, PhD, Professor of Internal Medicine and Pulmonology at the University of Heidelberg, Germany
    “The role of pulmonology in lung cancer screening”
  • To understand the status of lung cancer screening programs in the EU
  • To learn which steps are to be considered in setting up a lung screening program
  • To understand the learnings in setting up a lung screening program
  • To learn how AI can be used in lung screening
  • To understand the role of pulmonology in the lung cancer screening process
  • Dr. Sebastian Schmidt, Head of CT Strategy, Innovation & Medical Affairs at Siemens Healthineers, Germany
  • Prof. Marie Pierre Revel, Head of Radiology department at Cochin hospital, France
  • Prof. Dr. med. Hans-Ulrich Kauczor, Head of clinic for diagnostic and interventional radiology at Heidelberg University Hospital, Germany
  • Mélisande Rouger, ESR moderator
  • To understand the main benefit of AI in lung cancer screening
  • To evaluate the importance of lung screening and the role of radiologists in driving its implementation
  • To analyze the potential and challenges of using AI in lung cancer screening
  • To understand how AI can improve lung cancer screening by analyzing medical imaging data
  • To identify non-oncological factors that should be considered when performing lung cancer screening
  • General considerations: Steps towards the implementation of lung cancer screening programs at European level (Dr. Sebastian Schmidt, Head of CT Strategy, Innovation & Medical Affairs at Siemens Healthineers)
  • Lung cancer screening in the UK: Experiences and insights in a trailer-based program (Professor Richard Booton2 PhD FRCP, Consultant Respiratory Physician, Honorary MAHSC Clinical Professor & Clinical Director, Directorate of Lung Cancer & Thoracic Surgery, North West Lung Centre, Wythenshawe Hospital, Manchester, UK)
  • Lung cancer screening in Poland: Organizational program set-up (Joanna Bidzińska2, Ph.D., EMBA, Project coordinator of National Lung Cancer Screening in the University Clinical Centre in Gdańsk for the northern Macroregion of Poland)
  • Q&A
  • Why is lung cancer screening a critical factor in reducing lung cancer mortality?
  • What is the status of lung cancer screening programs in the EU?
  • How can a screening program be implemented?
  • What are possible approaches on how to set up a lung cancer screening program?
  • What are the lessons or pitfalls?
  • Experience with the implementation of LCS in Poland: How Poland set up their lung cancer screening program, Radiologist and lung cancer screening. Polish experience (Prof. Witold Rzyman2, Gdansk / Poland)
  • CT Technologies for Lung Cancer Screening: Which technology parameters are important to achieve good quality images at ultra low dose, what needs to be considered in finding your local LCS protocol (Prof. Dr. Marc Kachelrieß2, Heidelberg / Germany)
  • The role of Artificial Intelligence (AI) in a LCS Program: Identifying smoking-related disease on LCS CT scans, the role of AI in LCS (Prof. Philippe Grenier2, Suresnes, France)
  • Q&A